treatment with prostaglandin e1 is recommended for infants with interruption of the aortic arch , critical coarctation of the aorta , and other lesions in which systemic perfusion is limited by a restrictive ductus arteriosus .
C0002335
prostaglandin e1
C0003492
coarctation of the aorta